Showing results (491-500 of 729) with videos related to
Sort By:
Pageof 73
American Heart Journal|December 3, 2014
Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trialsAkshay Bagai, Mary Tan, Carlo Di Mario, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 26, 2017
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU RegistryPiera Capranzano, Davide Capodanno, Salvatore Brugaletta, et al.Heart (British Cardiac Society)|March 9, 2007
64-Slice CT coronary angiography in patients with non-ST elevation acute coronary syndromeWillem B Meijboom, Nico R Mollet, Carlos A Van Mieghem, et al.The American Journal of Cardiology|April 24, 2017
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery DiseaseAakash Garg, Sunil V Rao, Sahil Agrawal, et al.Cancers|February 13, 2025
Lesion Conspicuity in Contrast-Enhanced Mammography: A Retrospective Analysis of Tumor CharacteristicsChiara Bellini, Tommaso Susini, Kassandra Toncelli, et al.Radiology|August 20, 2008
Optimal electrocardiographic pulsing windows and heart rate: effect on image quality and radiation exposure at dual-source coronary CT angiographyAnnick C Weustink, Nico R Mollet, Francesca Pugliese, et al.Open Heart|June 21, 2019
Trial protocol for the validation of the 'Toronto Aortic Stenosis Quality of Life (TASQ) Questionnaire' in patients undergoing surgical aortic valve replacement (SAVR) or transfemoral (TF) transcatheter aortic valve implantation (TAVI): the TASQ registryDerk Frank, Simon Kennon, Nikolaos Bonaros, et al.JACC. Cardiovascular Interventions|September 26, 2009
Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudyJoanna J Wykrzykowska, Patrick W Serruys, Yoshinobu Onuma, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 22, 2017
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended RegistryBoris Schnorbus, Jens Wiebe, Davide Capodanno, et al.International Journal of Cardiology|February 1, 2016
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study)Simone Biscaglia, Fabrizio Ugo, Alfonso Ielasi, et al.Pageof 73